Researchers at the University of Georgia and Sanofi Pasteur, the vaccines division of Sanofi, announced today the development of a vaccine that protects against multiple strains of both seasonal and pandemic H1N1 influenza in mouse models.
They published their findings recently in the Journal of Virology.
Researchers from UGA and Sanofi Pasteur, which has a research and development collaboration agreement with UGA, will present their data tomorrow, March 30, at the World Vaccine Congress US 2016 in Washington, D.C.
“One of the problems with current influenza vaccines is that we have to make predictions about which virus strains will be most prevalent every year and build our vaccines around those predictions,” said Ted Ross, director of UGA’s Center for Vaccines and Immunology and Georgia Research Alliance Eminent Scholar in Infectious Diseases in the College of Veterinary Medicine. “What we have developed is a vaccine that protects against multiple different strains of H1N1 virus at once, so we might be able to one day replace the current standard of care with this more broadly cross-protective vaccine.”
The H1N1 influenza virus caused a worldwide pandemic in 2009. When it was first detected, it was called swine flu because the virus was similar to those found in pigs, but the virus now circulates as a seasonal form of influenza.
Using a technique called Computationally Optimized Broadly Reactive Antigen, or COBRA, UGA researchers Donald Carter, Christopher Darby and Bradford Lefoley, along with Ross, created nine prototype synthetic compound vaccines constructed using genetic sequences from multiple influenza virus strains.
The COBRA vaccines were designed to recognize H1N1 viruses isolated within the last 100 years, but many of the experimental vaccines produced immunity against influenza strains not included in the design. This means that scientists may be able to produce a vaccine that not only protects against recognized seasonal and pandemic influenza strains, but also strains that have yet to be discovered.
Because this vaccine is generated from the genetic sequences of multiple flu viruses, it may protect against many strains over several years, Ross said. That would also allow for year-round manufacturing of the vaccine, since scientists would not have to halt production every year to identify the most prevalent strains.
This research is part of a broader effort to create a universal influenza vaccine, which would protect against all strains of the virus.
“We still have some work to do before we get a truly universal flu vaccine,” Ross said. “But the COBRA vaccine we’ve developed for H1N1 virus subtypes is a major step in the right direction.”
The Latest on: Flu vaccine
via Google News
The Latest on: Flu vaccine
- Quadrivalent Flu Vaccine Market Analysis by Competitors, Industry Trends & Outlook 2019-2025on April 8, 2020 at 12:47 am
The MarketWatch News Department was not involved in the creation of the content. Apr 08, 2020 (HTF Market Intelligence via COMTEX) -- Quadrivalent Flu Vaccine Market explores effective study on varied ...
- Common coronaviruses are sharply seasonal and appear to transmit like influenzaon April 7, 2020 at 7:49 pm
Of the seven coronaviruses known to infect people, four cause common respiratory infections that are sharply seasonal and appear to transmit similarly to influenza, according to a new study by ...
- COLUMN-Coronavirus lockdowns: can we learn from the 1918 influenza pandemic? Kempon April 7, 2020 at 6:01 pm
Pandemics Depress the Economy, Public Health Interventions Do Not: Evidence from the 1918 Flu”, was published by Sergio Correia, Stephan Luck and Emil Verner on March 26. “We find that cities that ...
- IFN-κ suppresses the replication of influenza A viruses through the IFNAR-MAPK-Fos-CHD6 axison April 7, 2020 at 11:55 am
He et al. found that IFN-κ was produced in the lungs of mice early after infection with various influenza A viruses (IAVs). In cultured human lung epithelial cells, IFN-κ inhibited IAV replication by ...
- SARS-CoV-2 detection in patients with influenza-like illnesson April 7, 2020 at 2:39 am
We re-analysed 640 throat swabs collected from patients in Wuhan with influenza-like-illness from 6 October 2019 to 21 January 2020 and found that 9 of the 640 throat swabs were positive for ...
- US Influenza Activity Dropping, but Hospitalizations Up, CDC Sayson April 7, 2020 at 2:04 am
Influenza activity is decreasing in the United States, but hospitalization rates rose slightly, according to an April 3 report from the Centers for Disease Control and Prevention (CDC). The number of ...
- Pandemic Influenza Vaccine Market Research Report 2019-2025: By Product, Application, Manufacturer, Sales and Segmentationon April 7, 2020 at 1:49 am
Apr 07, 2020 (Profound via COMTEX) -- The report provides rational insights along with historical and forecast data to said in better understanding of the Global Pandemic Influenza Vaccine Market. The ...
- Lessons learned in Denver from 1918 influenza pandemicon April 6, 2020 at 7:48 pm
As World War I was coming to an end, a new war of a different kind was just beginning in Colorado. A deadly influenza pandemic spread across Colorado and around the world in 1918.
- The global influenza vaccine market is estimated to record a CAGR of 6.43% over the forecast period of 2020-2028on April 6, 2020 at 5:20 pm
KEY FINDINGS The global influenza vaccine market is estimated to record a CAGR of 6.43% over the forecast period of 2020-2028. A surge in ...
- What Can Images of the 1918 Influenza Pandemic Teach Us About COVID-19?on April 6, 2020 at 2:58 pm
In 1918, a flu pandemic ripped through the globe, infecting one-third of the world population and killing more than 50 million people. Known as the Spanish Flu, or the 1918 Influenza Pandemic, it was ...
via Bing News